Legacy Edge Advisors’s Merck MRK Stock Holding History

Legacy Edge Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,125	Closed	-$376K	–	222
2026 Q1	$376K	Buy	3,125 +513	+20%	+$59.2K	0.04%	163
2025 Q4	$275K	Buy	+2,612	New	+$245K	0.03%	190

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Legacy Edge Advisors's MRK Position: Q2 2026 in Review

Legacy Edge Advisors sold out of Merck (MRK) in Q2 2026, closing a stake of 3,125 shares — an estimated $376K sold.

Legacy Edge Advisors first reported a position in MRK in Q4 2025 and held it in 2 quarters. The position peaked at $376K in Q1 2026. 2,688 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Legacy Edge Advisors reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
Legacy Edge Advisors sold 3,125 Merck shares in Q2 2026, an estimated $376K.
Legacy Edge Advisors first reported a position in Merck in Q4 2025 and held it in 2 quarters.
Legacy Edge Advisors's Merck position peaked at $376K in Q1 2026.
2,688 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Legacy Edge Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.